2qlq
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
- | 2QLQ is a | + | 2QLQ is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2QLQ OCA]. |
==Reference== | ==Reference== | ||
- | + | <ref group="xtra">PMID:18316192</ref><references group="xtra"/> | |
[[Category: Gallus gallus]] | [[Category: Gallus gallus]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
- | [[Category: | + | [[Category: Gruetter, C.]] |
- | [[Category: | + | [[Category: Michalczyk, A.]] |
+ | [[Category: Rauh, D.]] | ||
+ | [[Category: Rode, H B.]] | ||
[[Category: Alternative splicing]] | [[Category: Alternative splicing]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
Line 44: | Line 46: | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 22 11:25:42 2010'' |
Revision as of 08:16, 22 September 2010
Crystal structure of SRC kinase domain with covalent inhibitor RL3
Template:ABSTRACT PUBMED 18316192
About this Structure
2QLQ is a 2 chains structure with sequences from Gallus gallus. Full crystallographic information is available from OCA.
Reference
- Michalczyk A, Kluter S, Rode HB, Simard JR, Grutter C, Rabiller M, Rauh D. Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR. Bioorg Med Chem. 2008 Apr 1;16(7):3482-8. Epub 2008 Feb 20. PMID:18316192 doi:10.1016/j.bmc.2008.02.053
Page seeded by OCA on Wed Sep 22 11:25:42 2010
Categories: Gallus gallus | Non-specific protein-tyrosine kinase | Gruetter, C. | Michalczyk, A. | Rauh, D. | Rode, H B. | Alternative splicing | Atp-binding | Drug resistance | Irreversible inhibitor | Kovalent inhibitor | Lipoprotein | Myristate | Nucleotide-binding | Phosphorylation | Proto-oncogene | Sh2 domain | Sh3 domain | Src kinase domain | Transferase | Tyrosine-protein kinase